MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Aug 20, 12:16 PM (EDT)
Price
$14.16
Change
-$0.02 (-0.14%)
Capitalization
11.84B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Aug 19, 2025

RDY's RSI Oscillator recovers from oversold territory

The RSI Oscillator for RDY moved out of oversold territory on August 07, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on RDY as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on August 13, 2025. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

RDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for RDY crossed bearishly below the 50-day moving average on July 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RDY entered a downward trend on August 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.951) is normal, around the industry mean (16.078). P/E Ratio (18.220) is within average values for comparable stocks, (72.781). Projected Growth (PEG Ratio) (3.127) is also within normal values, averaging (4.677). RDY has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.031). P/S Ratio (3.096) is also within normal values, averaging (40.400).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to rise 12.55% to 22 cents per share on October 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q3'25
Est.
$0.23
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on July 23 showed earnings per share of 20 cents, missing the estimate of 20 cents. With 82.11K shares outstanding, the current market capitalization sits at 11.84B.
A.I.Advisor
published Dividends

RDY paid dividends on August 06, 2025

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $0.09 per share was paid with a record date of August 06, 2025, and an ex-dividend date of July 25, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NVOH29.920.42
+1.42%
NOVO NORDISK A/S (B SHARES) ADRHEDGED NVOH
DGZ6.960.09
+1.32%
DB Gold Short ETN
SH38.700.22
+0.57%
ProShares Short S&P500
AVMV67.960.18
+0.27%
Avantis U.S. Mid Cap Value ETF
FEDM56.46N/A
-0.01%
FlexShares ESG&Clmt Dev Mkts ex-US Cr

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
-0.35%
COLL - RDY
30%
Poorly correlated
-1.47%
HROW - RDY
29%
Poorly correlated
-0.23%
AMPH - RDY
28%
Poorly correlated
+1.92%
VTRS - RDY
28%
Poorly correlated
+0.47%
AMRX - RDY
26%
Poorly correlated
+0.76%
More

Groups containing RDY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
-0.35%
Pharmaceuticals: Generic
industry (225 stocks)
9%
Poorly correlated
-0.47%